DAX-0,07 % EUR/USD-0,03 % Gold-0,24 % Öl (Brent)-0,48 %

Clarivate Analytics expands global life science alliances program with three new technology partners

Nachrichtenquelle: PR Newswire (engl.)
05.12.2019, 15:05  |  107   |   |   

Enabling extended use of its life science intelligence solutions to help companies accelerate innovation

LONDON and PHILADELPHIA, Dec. 5, 2019 /PRNewswire/ -- Clarivate Analytics plc (NYSE: CCC; CCC.WS), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced that it has signed alliance agreements with three new technology partners. The partnerships will see Clarivate combine content from its Cortellis suite of life science intelligence solutions with partners' tools and technologies to help drug and medical device developers be better positioned for clinical and financial success.

Clarivate Analytics logo

The new partners include:

Blueprint Systems
Blueprint Systems is a Gartner-recognized agile planning and compliance management software provider that accelerates and de-risks the digital transformation of large organizations. Its exclusive collaboration with Clarivate tackles one of the biggest challenges in life sciences—efficiently and successfully managing the complex regulatory compliance and GxP process.

Copyright Clearance Center
Copyright Clearance Center (CCC) provides solutions that combine licensing, content, software and professional services to advance the way companies integrate, access and share information. Through its partnership with Clarivate, CCC has expanded the capabilities of its RightFind Navigate discovery solution, which provides contextualized information retrieval of internal and external data to meet the specific needs of each user.

Remarque Systems
A leader in innovative clinical research methods, Remarque Systems optimizes clinical trials through data using its cloud-based platform. Clarivate and Remarque are exploring ways to leverage Cortellis Clinical Trials intelligence in Remarque's AI-driven quality oversight and trial optimization software.

"Partnering with these innovative technology companies demonstrates how Clarivate continues to deliver improved value to drug and medical device developers by unlocking hidden insights in data," said Gavin Coney, Global Head of Science Group Alliances for Clarivate Analytics. "Our vision is to improve how the world advances innovation. One way we do this is by partnering with forward-looking companies that can add considerable value to our solutions. Specifically, these three partnerships will help us combine expertise and tools to create solutions that address some of the industry's most urgent challenges, such as new scientific discoveries, regulatory compliance, efficient clinical development and more proactive risk management. These partners are the latest to join our life science alliance program, announced earlier this year."

Seite 1 von 2
Clarivate Analytics Aktie jetzt für 4€ handeln - auf Smartbroker.de

Diesen Artikel teilen
Mehr zum Thema
Klicken Sie auf eines der Themen und seien Sie stets dazu informiert. Mehr Informationen hier.

0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren



Aus der Community
LUS Wikifolio-Index Performance von Kryptowährungen Index Zertifikat Open-End (LASW)
Chart: arniarni

Meistgelesene Nachrichten des Autors